|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 250, Issue 6 960-R972, Copyright © 1986 by American Physiological Society
ARTICLES |
J. E. Hall
Angiotensin II (ANG II) is one of the body's most powerful regulators of Na excretion, operating through extrarenal mechanisms, such as stimulation of aldosterone secretion, as well as intrarenal mechanisms. Considerable evidence suggests that the intrarenal actions of ANG II are quantitatively more important than changes in aldosterone secretion in the normal day-to-day regulation of Na balance and arterial pressure. ANG II at physiological concentrations increases proximal tubular reabsorption, but further studies are needed to determine whether ANG II also has an important effect on more distal tubular segments. ANG II also markedly constricts efferent arterioles, tending to increase Na reabsorption by altering peritubular capillary physical forces and also helping to prevent excessive decreases in glomerular filtration rate. ANG II may also decrease Na excretion and increase urine concentrating ability by reducing renal medullary blood flow. Regulation of Na excretion by ANG II is closely linked with arterial pressure control and volume homeostasis through the renal pressure natriuresis mechanism. Under many physiological conditions, such as changes in Na intake, ANG II greatly multiplies the effectiveness of the pressure natriuresis mechanism to prevent fluctuations in body fluid volume and arterial pressure. In circumstances associated with circulatory depression, such as decreased cardiac function, reductions in blood pressure and increased ANG II formation cause Na retention until arterial pressure is restored to normal. However, in pathophysiological conditions in which ANG II is inappropriately elevated, increased arterial pressure (hypertension) is required for the kidney to "escape" the potent antinatriuretic actions of ANG II and to return Na excretion to normal via the pressure natriuresis mechanism.
This article has been cited by other articles:
![]() |
M. Maliszewska-Scislo, H. Chen, R. A. Augustyniak, D. Seth, and N. F. Rossi Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R741 - R750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Pojoga, T. M. Yao, S. Sinha, R. L. Ross, J. C. Lin, J. D. Raffetto, G. K. Adler, G. H. Williams, and R. A. Khalil Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1258 - H1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Chappell, L. M. Yamaleyeva, and B. M. Westwood Estrogen and salt sensitivity in the female mRen(2).Lewis rat Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1557 - R1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil Dietary salt and hypertension: new molecular targets add more spice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R509 - R513. [Full Text] [PDF] |
||||
![]() |
P. M. O'Connor, M. M. Kett, W. P. Anderson, and R. G. Evans Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow Am J Physiol Renal Physiol, March 1, 2006; 290(3): F688 - F694. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lerolle, S. Bourgeois, F. Leviel, G. Lebrun, M. Paillard, and P. Houillier Angiotensin II inhibits NaCl absorption in the rat medullary thick ascending limb Am J Physiol Renal Physiol, September 1, 2004; 287(3): F404 - F410. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Le, M. I. Oliverio, H.-S. Kim, H. Salzler, R. C. Dash, D. N. Howell, O. Smithies, S. Bronson, and T. M. Coffman A {gamma}GT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice Physiol Genomics, August 11, 2004; 18(3): 290 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Osborn, P. Ariza-Nieto, J. P. Collister, S. Soucheray, B. Zimmerman, and S. Katz Responsiveness vs. basal activity of plasma ANG II as a determinant of arterial pressure salt sensitivity Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2142 - H2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Mangrum, R. A. Gomez, and V. F. Norwood Effects of AT1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake Am J Physiol Renal Physiol, September 1, 2002; 283(3): F447 - F453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schou, A. Gabrielsen, N. E. Bruun, P. Skott, B. Pump, H. Dige-Petersen, E. Frandsen, P. Bie, J. Warberg, N. J. Christensen, et al. Angiotensin II attenuates the natriuresis of water immersion in humans Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R187 - R196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi, D. G. Warnock, and P. D. Bell Angiotensin II Directly Stimulates ENaC Activity in the Cortical Collecting Duct via AT1 Receptors J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1131 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Pratt, G. J. Eckert, S. Newman, and W. T. Ambrosius Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive Subjects Hypertension, November 1, 2001; 38(5): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Boesch and J. L. Garvin Age-dependent activation of PKC isoforms by angiotensin II in the proximal nephron Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R861 - R867. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, K. Cockrell, F. D. Cline, M. T. Llinas, M. Sedeek, and J. P. Granger Effect of Angiotensin II Synthesis Blockade on the Hypertensive Response to Chronic Reductions in Uterine Perfusion Pressure in Pregnant Rats Hypertension, September 1, 2001; 38(3): 742 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gabrielsen, P. Bie, N. H. Holstein-Rathlou, N. J. Christensen, J. Warberg, H. Dige-Petersen, E. Frandsen, S. Galatius, B. Pump, V. B. Sorensen, et al. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R459 - R467. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, K. L. Cockrell, A. N. Rinewalt, J. N. Herrington, and J. P. Granger Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1388 - R1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Peng, O. A. Carretero, M. E. Alfie, J. A. Masura, and N.-E. Rhaleb Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate-Salt Hypertensive Mice Lacking Ren-2 Gene Hypertension, March 1, 2001; 37(3): 974 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Simon and G. Illyes Structural Vascular Changes in Hypertension : Role of Angiotensin II, Dietary Sodium Supplementation, and Sympathetic Stimulation, Alone and in Combination in Rats Hypertension, February 1, 2001; 37(2): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, Y. Zhang, J. R. Ballew, G. Fink, and D. H. Wang Development of Hypertension Induced by Subpressor Infusion of Angiotensin II : Role of Sensory Nerves Hypertension, October 1, 2000; 36(4): 549 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Oliverio and T. M. Coffman Angiotensin II Receptor Physiology Using Gene Targeting Physiology, August 1, 2000; 15(4): 171 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Steele, L. G. Koch, and P. H. Brand State-Dependent Expression of Pressure Diuresis in Conscious Rats Experimental Biology and Medicine, June 1, 2000; 224(2): 109 - 115. [Abstract] [Full Text] |
||||
![]() |
M. I. Oliverio, C. F. Best, O. Smithies, and T. M. Coffman Regulation of Sodium Balance and Blood Pressure by the AT1A Receptor for Angiotensin II Hypertension, February 1, 2000; 35(2): 550 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paradis, N. Dali-Youcef, F. W. Paradis, G. Thibault, and M. Nemer Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling PNAS, January 18, 2000; 97(2): 931 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Girgrah, P Liu, J Collier, L Blendis, and F Wong Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis Gut, January 1, 2000; 46(1): 114 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Karam, J.-P. Clozel, P. Bruneval, M.-F. Gonzalez, and J. Menard Contrasting Effects of Selective T- and L-Type Calcium Channel Blockade on Glomerular Damage in DOCA Hypertensive Rats Hypertension, October 1, 1999; 34(4): 673 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Amiri and R. Garcia Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells Am J Physiol Renal Physiol, May 1, 1999; 276(5): F691 - F699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hunt, N. R. Cook, A. Oberman, J. A. Cutler, C. H. Hennekens, P. S. Allender, W. G. Walker, P. K. Whelton, and R. R. Williams Angiotensinogen Genotype, Sodium Reduction, Weight Loss, and Prevention of Hypertension : Trials of Hypertension Prevention, Phase II Hypertension, September 1, 1998; 32(3): 393 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, M. J. Sullivan, W. E. Dale, E. M. Hasser, E. H. Blaine, and J. T. Cunningham Fos-Like Immunoreactivity in the Medulla after Acute and Chronic Angiotensin II Infusion J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1165 - 1173. [Abstract] [Full Text] |
||||
![]() |
J. P. Collister and J. W. Osborn Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R357 - R366. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Melo, A. T. Veress, C. K. Chong, S. C. Pang, T. G. Flynn, and H. Sonnenberg Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R255 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Gonzalez, V. L. M. Herrera, and N. Ruiz-Opazo Renal Immunocytochemical Distribution and Pharmacological Properties of the Dual Angiotensin II/AVP Receptor Hypertension, April 1, 1997; 29(4): 957 - 961. [Abstract] [Full Text] |
||||
![]() |
H. Karam, D. Heudes, P. Bruneval, M.-F. Gonzales, B.-M. Loffler, M. Clozel, and J.-P. Clozel Endothelin Antagonism in End-Organ Damage of Spontaneously Hypertensive Rats: Comparison With Angiotensin-Converting Enzyme Inhibition and Calcium Antagonism Hypertension, September 1, 1996; 28(3): 379 - 385. [Abstract] [Full Text] |
||||
![]() |
A. Luchner, T. L. Stevens, D. D. Borgeson, M. M. Redfield, J. E. Bailey, S. M. Sandberg, D. M. Heublein, and J. C. Burnett Angiotensin II in the Evolution of Experimental Heart Failure Hypertension, September 1, 1996; 28(3): 472 - 477. [Abstract] [Full Text] |
||||
![]() |
J. P. Collister, B. J. Hornfeldt, and J. W. Osborn Hypotensive Response to Losartan in Normal Rats : Role of Ang II and the Area Postrema Hypertension, March 1, 1996; 27(3): 598 - 606. [Abstract] [Full Text] |
||||
![]() |
V. Gross, A. Lippoldt, W. Schneider, and F. C. Luft Effect of Captopril and Angiotensin II Receptor Blockade on Pressure Natriuresis in Transgenic TGR(mRen-2)27 Rats Hypertension, September 1, 1995; 26(3): 471 - 479. [Abstract] [Full Text] |
||||
![]() |
X. Ma, M. W. Chapleau, C. A. Whiteis, F. M. Abboud, and K. Bielefeldt Angiotensin Selectively Activates a Subpopulation of Postganglionic Sympathetic Neurons in Mice Circ. Res., April 27, 2001; 88(8): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |